Brain differential gene expression and blood cross-validation of a molecular signature of patients with major depressive disorder

INTRODUCTION: The agreement between clinicians diagnosing major depressive disorder (MDD) is poor. The objective of this study was to identify a reproducible and robust gene expression marker capable of differentiating MDD from healthy control (HC) subjects. MATERIALS AND METHODS: Brain and blood ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez Rueda, Hugo, Bustillo, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071037/
https://www.ncbi.nlm.nih.gov/pubmed/35030558
http://dx.doi.org/10.1097/YPG.0000000000000309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071037/
https://www.ncbi.nlm.nih.gov/pubmed/35030558
http://dx.doi.org/10.1097/YPG.0000000000000309

Ejemplares similares